TREATMENT OF RECURRENT LIVER AUTOIMMUNE DISEASE AFTER TRANSPLANTATION WITH IL-2 RECEPTOR (DACLIZUMAB)
Creators
Antonio D Pinna
Deborah Weppler
Mariana Berho
Jose R Nery
Tomoaki Kato
Camillo Ricordi
Phillip Ruiz
Andreas G Tzakis
Publication Details
Transplantation, Vol.69(Supplement), pp.S320-S321
Academic Unit
Leadership Department; Miller School of Medicine; Diabetes Research Institute (DRI); UMMG Department of Pathology; UMMG Department of Surgery; UMMG Dept of Surgery - Div of General Surgery